Statement Of Financial Position [Abstract]

Innate Pharma - Filing #2821023

Concept As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
As at
2019-01-01
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
As at
2018-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
11 694 EUR
11 672 EUR
Intangible assets other than goodwill
46 289 EUR
96 968 EUR
Deferred tax assets
7 087 EUR
1 286 EUR
Trade and other receivables
51 635 EUR
28 716 EUR
139 012 EUR
Cash and cash equivalents
136 792 EUR
202 887 EUR
152 314 EUR
Assets
307 423 EUR
401 361 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
3 950 EUR
3 941 EUR
Share premium
372 131 EUR
369 617 EUR
Other reserves
355,000 EUR
472,000 EUR
Equity
156 476 EUR
63 984 EUR
3 950 EUR
372 131 EUR
355,000 EUR
155 976 EUR
20 759 EUR
369 617 EUR
217 416 EUR
134 912 EUR
3 941 EUR
472,000 EUR
3 197 EUR
299 932 EUR
137 961 EUR
167 119 EUR
3 049 EUR
1 099 EUR
121,000 EUR
299 932 EUR
167 240 EUR
1 099 EUR
3 049 EUR
3 197 EUR
137 840 EUR
121,000 EUR
Liabilities [abstract]
Trade and other payables
29 519 EUR
36 047 EUR
34 662 EUR
Deferred tax liabilities
7 087 EUR
1 286 EUR
Equity and liabilities
307 423 EUR
401 361 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.